Cleared Special

K021927 - PLATELET CONCENTRATE SEPARATION KIT FOR CELSEP CENTRIFUGE SYSTEM (FDA 510(k) Clearance)

Jul 2002
Decision
30d
Days
Class 1
Risk

K021927 is an FDA 510(k) clearance for the PLATELET CONCENTRATE SEPARATION KIT FOR CELSEP CENTRIFUGE SYSTEM. This device is classified as a Equipment, Laboratory, General Purpose, Labeled Or Promoted For A Specific Medical Use (Class I - General Controls, product code LXG).

Submitted by Biomet, Inc. (Warsaw, US). The FDA issued a Cleared decision on July 12, 2002, 30 days after receiving the submission on June 12, 2002.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 862.2050.

Submission Details

510(k) Number K021927 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2002
Decision Date July 12, 2002
Days to Decision 30 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code LXG — Equipment, Laboratory, General Purpose, Labeled Or Promoted For A Specific Medical Use
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.2050